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41. SUMMARY
Under intensive production systems, the greatest potential for effecting increases
in production and economic efficiency in the beef cow herd lies in the possibility
of increasing the frequency of twin births. Embryo transfer is technically a
successful method of inducing twin births in cattle. While an embryo transfer
approach is too costly to allow commercial twinning, it has been used to show
that ovulation rate and not uterine capacity is the limiting factor in increasing the
reproductive rate of the cow. While ovulation of one or more viable oocytes is
central to normal reproduction, knowledge of the control of ovulation and of
folliculogenesis on which ovulation depends, is limited. In spite of the fact that
many follicles are subjected to the same endogenous hormonal environment and
theoretically should all be capable of ovulating, only a tiny proportion do. While
gonadotrophic hormones play a central role in ovarian follicle development and
ovulation, their action at the ovarian level seems to be controlled by intra-ovarian
factors. This intra-ovarian control of ovulation is thought to be exerted partly by
the hormone inhibin and partly by other, as yet, unidentified compounds in
follicular fluid. This project focused on identification and isolation of ovarian
compounds involved in the control of ovulation rate, followed by immunisation
against these compounds in order to study the effect on ovulation and the twin
calving rates. The main results are summarised here and detailed results have
been published in the papers listed at the end of this report.
Isolation of ovulation controlling compounds in cattle
Isolation of granulosa cell inhibitory factor
A novel compound with a number of major biological effects, implicated in
ovulation control, has been isolated from cattle ovarian follicles.
• At very low concentrations  it markedly inhibits granulosa cell proliferation in
vitro. 
• It selectively inhibits the proliferation of granulosa cells from small and
medium sized follicles but has no effect on cells from large follicles.
• Its effect is specific to ovarian follicles. 
This is a novel ovarian compound, previously unidentified and now termed
“granulosa cell inhibitory factor” or GCIF. Based on elution position on the gel
filtration columns, it is probable that the molecular weight of GCIF is <5 kDa. 
The evidence from this study suggests that the GCIF described here may well be
one of the specific inhibitor(s) produced by the dominant follicle and involved in
the inhibition of subordinate follicles. This hypothesis is supported by the
susceptibility of granulosa cells from small and medium follicles to inhibition by
GCIF. Evidence that production of GCIF is greatest in large dominant follicles
lends even more support to this hypothesis. 
Isolation of inhibin
A partly purified inhibin preparation was isolated from steroid free follicular fluid
by sequential chromatography.
• The biological activity of the inhibin preparation was measured by an in vitro
bioassay by determining its capacity to inhibit FSH secretion by rat pituitary
cells in culture. 
• Following partial purification the biological activity of the inhibin preparation
was increased by 200-fold compared with starting follicular fluid and inhibited
FSH secretion by 60% in the in vitro bioassay.
• Electrophoresis revealed that the inhibin preparation had an apparent
molecular mass of 68kDa. 
Immunisation against GCIF or inhibin and ovulation rate
GCIF and ovulation rate
Sheep were used as a model in the immunisation studies as the supply of partly
purified inhibin was insufficient to immunise cattle. 
• Ovulation rate over 8 boosts was increased in GCIF immunised sheep.
• The overall mean was 2.75±0.15 ovulations for the GCIF immunised and
1.85±0.12 for control immunised sheep. 
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• Immunisation against GCIF increased the average ovulation rate by 36% with
the maximum increase (140%) recorded following the third boost.
• This increase in ovulation rate was the result of a greater number of sheep
having 3 ovulations rather than a smaller number having very high ovulation
rates.
Inhibin peptides  and ovulation rate
Inhibin peptides from the amino acid sequence of inhibin were identified by
computer analysis as likely immunological epitopes and were used in
immunisation studies.
• Immunisation of cattle against inhibin peptides generated an immune
response to inhibin and resulted in up to 80% of heifers in one of the
immunised groups responding with twin-ovulations.
• The increase in ovulation rate was mainly confined to twin ovulations and to
the cycle following  each boost. Ten of the 15 immunised (67%) and 4 of 5
control (80%) heifers conceived to first service while 60% of  heifers in one
of the peptide immunised group gave birth to twin calves.
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2. INTRODUCTION
The combination of single calving and a nine-month gestation length inherently
limits output and profit margins of beef cow enterprises. In this context the
greatest potential for effecting higher biological and economic efficiencies lies in
the possibility of increasing the frequency of twin births. In earlier twin embryo
transfer studies, carried out at the Teagasc, Belclare Research Centre we
showed that it is the ovulation rate and not uterine capacity that limits the
frequency of twin births in cattle. In animal research institutions world-wide
several approaches including, genetic selection, embryo transfer, hormone
administration and controlling the ovulation rate have been followed in attempts
to increase the incidence of multiple births in cattle. In the project outlined in this
report the approach taken was based on attempts to control ovulation rate. While
ovulation of one or more viable oocytes is central to normal reproduction,
knowledge of the control of ovulation and of folliculogenesis on which ovulation
depends, is limited. In spite of the fact that many follicles are subjected to the
same endogenous hormonal environment and theoretically should all be capable
of ovulating, only a tiny proportion do. While gonadotrophic hormones play a
central role in ovarian follicle development and ovulation, their action at the
ovarian level seems to be controlled by intra-ovarian factors. This intra-ovarian
control of ovulation is thought to be exerted partly by the hormone inhibin and
partly by other, as yet, unidentified compounds in follicular fluid. This project
focused on identification and isolation of ovarian compounds involved in the
control of ovulation rate, followed by immunisation against these compounds in
order to study the effect on ovulation and the twin calving rates. The main results
are summarised here and detailed results have been published in the papers listed
at the end of this report.
Objective
The overall objective of the project was to increase ovulation and twin calving
rates in cattle and this was addressed in a series of studies, the results of which
are summarised in this report. Detailed and more comprehensive results have
been published in the series of papers listed at the end of the report.
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3. ISOLATION OF OVULATION CONTROLLING 
COMPOUNDS IN CATTLE
For the isolation of ovulation controlling compounds follicular fluid was aspirated
from cattle ovarian follicles, charcoal treated to remove steroids and a low
(<10kDa) or high (>10kDa molecular weight fraction prepared by
ultrafiltration. The objective of this study was to isolate compound(s) from cattle
follicular fluid that are involved in ovulation control. The results of a number of
experiments are summarised below. 
Experiment 1: Purification and in vitro testing of  low molecular weight
fractions isolated from cattle ovarian follicles.
The low molecular weight fraction of bovine follicular fluid was run on a series
of gel filtration columns to separate it into different molecular weight fractions.
The different fractions were tested for biological activity using a standard test
which involved measuring the effect of different concentrations of each fraction
on the proliferation of ovarian follicle granulosa cells. Gel filtration of the
prepared bovine follicular fluid by Sephadex G-25 chromotography resulted in a
consistent elution profile comprising seven distinct fractions. Similar elution
profiles were also found for follicular fluid isolated from the follicles of sheep, and
horses (Fig. 1).  The elution volumes, fraction volumes and peptide equivalent
content of all seven fractions isolated from bovine follicular fluid are shown in
Table 1. 
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9Fig. 1. The chromatographic elution profile of a low molecular weight fraction of
bovine, equine and ovine follicular fluid.
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Table 1. The recovery of peptide equivalent material from 10 mg of the
LMW  fraction of bovine follicular fluid following fractionation on a
Sephadex G-25 column.
Peak No. Elution volume Peak volume Peptide equivalent
(ml) (ml) (mg)
1 33.80 7.00 0.14
2 67.60 8.60 0.26
3 77.80 11.00 0.40
4 85.40 9.00 1.07
5 96.60 12.20 0.47
6 113.60 21.00 4.04
7 136.00 18.60 0.81
_ _ _ _
The biological effect of each of these fractions, measured in terms of their effect
on  granulosa cell proliferation in vitro is shown in Fig 2. Only Fractions 3 and
4 had a significant effect on granulosa cell proliferation. Fraction 3 stimulated
(P<0.01) and fraction 4 significantly inhibited (P<0.01) cell proliferation in
each case. Further tests showed that the inhibitory effect of Fraction 4 on cell
proliferation was not due to either a toxicity effect or to inhibition of cell
attachment. 
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Fig. 2.  Effect of various peaks from the G-25 chromatographic separation of the
low molecular weight fraction of follicular fluid on granulosa cell proliferation
as measured by haemocytometric cell counting. Peptide equivalent
concentrations of the various peaks are shown as follows:- 0 ng ml -1,     ; 10 ng
ml -1,     ; 100 ng ml -1,     ; 1000 ng ml -1,      .  
Values are means±SEM based on the following numbers of replicates:-  
4 replicates for peaks 1, 2, 3, 5 and 7; 14 replicates for peak 4 and 8 replicates for
peak 6. Control mean cell numbers for the various peaks varied from 44-68 x 104
ml -1.
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Experiment 2: The effect of inhibitory Fraction 4 on proliferation of
granulosa cells from small (<2 mm), medium (2-10 mm) or large
follicles (10-20 mm).
Fraction 4 inhibited the proliferation of granulosa cells from small (P<0.01) and
medium-sized (P<0.01) follicles but had no effect on granulosa cells from large
follicles (Fig. 3).
The specific nature of the effect on ovarian follicle cell proliferation was then
established by demonstrating its failure to affect proliferation of the cells of other
organ tissues. 
These results demonstrate clearly that bovine follicular fluid contains a low
molecular weight fraction (Fraction 4) with the following major biological
effects:-  (1)  at  very  low  concentrations  it  markedly  inhibits  granulosa  cell
11
Fig.3. Effects of peak 4 isolated from a population of mixed follicles on the
proliferation of granulosa cells at 0.01 ng/ml, (    ); 0.10ng/ml (    ) and 1.0ng/ml,    
( ) monitored by [3H]thymidine incorporation into acid-precipitable material.
Values are expressed as a percentage of control ± sem.
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proliferation in vitro, (2) it selectively inhibits the proliferation of granulosa cells
from small and medium sized follicles but has no effect on cells from large
follicles, (3) its effect is specific to ovarian follicles. This is a novel ovarian
fraction, previously unidentified and now termed “granulosa cell inhibitory factor”
or GCIF. Based on elution position on the Sephadex gel filtration columns, it is
probable that the molecular weight of GCIF is <5 kDa. 
The evidence from this study suggests that the GCIF described here may well
be one of the specific inhibitor(s) produced by the dominant follicle and involved
in the inhibition of subordinate follicles. This hypothesis is supported by the
susceptibility of granulosa cells from small and medium follicles to inhibition by
GCIF. Evidence that production of GCIF is greatest in large dominant follicles
lends even more support to this hypothesis. 
It is interesting to speculate that a very useful property of a factor produced by
a dominant follicle to suppress competing follicles would be the ability to inhibit
the granulosa cells of the competing follicle on both ovaries at very low
concentrations coupled with an inability to inhibit granulosa cells at high
concentrations such as might be found in the dominant follicle producing it.
Experiment 3: Purification  and in vitro testing of inhibin isolated from
cattle ovarian follicles.
Inhibin was isolated from the high molecular weight (>10kDa) fraction of
steroid free follicular fluid by sequential chromatography on affinity (Red
Sepharose) and ion exchange columns (Mono Q). The activity of inhibin in this
preparation was increased 207-fold over starting material with an overall
recovery of activity of 3% (Table 2). The biological activity of the inhibin
preparation was measured by an in vitro bioassay by determining its capacity to
specifically inhibit FSH secretion by rat pituitary cells in culture without affecting
LH secretion. This inhibin preparation was effective in suppressing FSH
secretion by 60% with no effect on LH concentrations. (Table 3). These data
indicate that inhibin is present at very low concentrations in the bovine follicle as
approximately 1 mg of this active fraction was recovered from a total of 50 ml
(3000mg) of bovine follicular fluid. Electrophoresis of the preparation was
carried out and revealed the presence of one protein which migrated with an
apparent molecular mass of 68kDa. This inhibin preparation was used for the
immunisation studies.
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Table 3.  Mean production of FSH and LH by 100,000 rat pituitary cells
after 72 hr in culture in the presence or absence of 2µg of inhibin
purified from bovine follicular fluid.
Treatment FSH (ng/ml) LH (ng/ml)
Control 31.7 ± 5.72 11.2 ± 1.27
Inhibin 14.1 ± 3.89 * 12.0 ± 1.21
* Significantly different from control (P<0.05)
Table 2.   Relative specific activity (RSA) and recovery of inhibin from
bovine follicular fluid following chromatography on Red Sepharose  and
Mono Q at pH 7.9 and pH  9.2.
Purification Step RSA (Overall) Recovery (%) (Overall)
Follicular Fluid 1 (1) 100 (100)
Red Sepharose 8-12 (8-12) 28-37 (28-37)
Mono Q  @ pH 7.9 2.5-3.7 (20-46) 28-35 ( 8-13)
Mono Q  @ pH 9.2 4.5 (207)* 24 (3.2)
* The most active fraction had a relative specific activity (RSA) of 335.
4. IMMUNISATION AGAINST GCIF OR INHIBIN AND 
OVULATION RATE
Immunisation against GCIF and ovulation rate
The purpose of this experiment was to determine whether active immunisation
against GCIF derived from bovine follicular fluid could elicit an immune response
in sheep and affect ovulation rate.
The GCIF was isolated, purified and tested for granulosa cell inhibitory activity as
described above and was then conjugated to human serum albumin for
immunisation studies. Because of the small amount of follicular fluid and
consequently the minute amounts of GCIF available following the
chromatographic isolation and purification procedures, sheep were used as the
model. Ewes of Cambridge and Belclare ancestry were immunised against a
GCIF-HSA conjugate. Control ewes were immunised against either HSA alone or
a GnRH-HSA conjugate. A total of eight booster injections were given at intervals
of 6-10 weeks after the primary immunisation over a period of two breeding
seasons. Blood samples were taken before primary injection and at regular
intervals for measurement of antibody titre. Antibody titres were measured using
a solid phase enzymeimmunoassay.  Because the GCIF fraction is not a pure
preparation, it was not possible to measure the antibody titres specifically raised
against GCIF.  Antibody titres against GnRH, however, were measured in all
ewes as an index of the efficiency of the conjugation and immunisation procedures
with a small peptide. Ovulation rate in all ewes was measured by mid-ventral
laparoscopy during the luteal phase of each relevant oestrous cycle. 
All sheep immunised against GnRH attained antibody titres greater than 1 in
60,000 by the end of the experiment (1 in 75,500±6,028 over all measurements
taken). This indicates that the peptide conjugation and immunisation procedures
used were efficient.
The effects of immunisation against GCIF on ovulation rate and follicle numbers
are shown in Fig. 4 and Tables 4 and 5. With the exception of the first boost,
ovulation rate over 8 boosts was increased in the GCIF immunised sheep (Fig.4
(a) and Table 4 ( P<0.01).
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Fig.4  Effect of immunization of  sheep with human serum albumin (HSA) alone
(     ), granulosa cell inhibitory factor GCIF -HSA (     ) or GnRH-HSA (     ) over
two breeding seasons on (a) ovulation rate and (b) number of follicles with a
diameter >3mm per animal. Sheep immunized with GnRH were boosted only
once. They did not ovulate after the first boost and had no follicles >3mm
diameter after the first breeding season. Values are mean±s.e.m. based on all
animals and 7 to 8 replicates. The overall ovulation rate was significantly
different from that of HSA immunized sheep (p<0.01). The number of follicles
for GCIF-and HAS-immunized sheep were not significantly different (P>0.05)
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The overall mean was 2.75±0.15 ovulations for the GCIF immunised and
1.85±0.12 for HSA immunised sheep. When only animals that had ovulated
were included in the analysis, immunisation against GCIF increased the average
ovulation rate by 36% (2.80±0.14 vs 2.05±0.13).  The maximum increase in
ovulation rate (140%) was recorded following boost 3 in GCIF immunised
animals.  When all animals were included in the analysis, immunisation against
GCIF increased ovulation rate by an average of 48%, with a maximum increase
of more than 180% following boost 3.
A frequency distribution table for ovulation rate (Table 4) shows that 50% of the
cycles of GCIF immunised sheep resulted in 3 or more ovulations compared to
only 21% of HSA immunised sheep. This increase in ovulation rate was the result
of a greater number of sheep having 3 ovulations rather than a smaller number
having very high ovulation rates.
The data from all cycles with one or more ovulations indicates that immunisation
against GCIF did not affect the numbers of cycles with ovulation on both sides.
In ovulating sheep that were immunised against HSA, in 32 of 58 cycles (55%)
there were no ovulations on one side in contrast to 27 of 55 cycles (49%) with
no ovulations on one side in ovulating sheep that were immunised against GCIF
(P>0.05). In contrast, the data from cycles with ovulations on one side only
clearly showed that immunisation with GCIF did increase the numbers of
ovulations on that side. Following immunisation against HSA, there were 15 of
32 cycles (47%) with two or more ovulations on the ovulating ovary in contrast
to 23 of 27 cycles (85%) with two or more ovulations in sheep that were
immunised against GCIF (P<0.01).
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Table 4. The frequency distribution of the ovulation rate for human serum
albumin (HSA) and granulosa cell inhibitory factor (GCIF)
immunized ewes
Ovulation rate class (%)
Immunization  Cycles 0 1 2 3 4 5 6
treatment
HSA 64 6(9) 15(23) 30(47) 8(13) 5(8) - -
GCIF-HSA 56 1(2) 4(7) 23(41) 15(27) 9(16) 3(5) 1(2)
The HSA and GCIF-HSA immunisation treatments were significantly different from 
each other (chi-squared test, P<0.01)
In contrast with the effects on ovulation, the effects of immunisation against
GCIF on follicles were much less marked. While the average number of follicles
of 3 mm or greater in diameter present on the ovaries was increased following
immunisation against GCIF (Fig. 4(b) and Table 5), this increase was neither
consistent nor significant (P>0.05).
Immunisation against GnRH inhibited ovulation.  In the first cycle following the
first boost no sheep at any stage had an antibody titre of less that 1 in 60,000.
This indicates that the peptide conjugation and immunisation procedures used
were efficient in eliciting a good immune response.
Immunisation of sheep against GCIF clearly increased ovulation rate. This
increase was maintained as animals were boosted into the second year of the
experiment. Because the GCIF fraction is a relatively crude fraction no effort
was made to obtain antibody titres against the active factor in immunised
animals.
If GCIF is a factor secreted by a dominant follicle or follicles to suppress growth
of other follicles, it is interesting to ask the question, whether, in multiple
ovulating animals such as the sheep, it acts mainly to inhibit follicles on the same
or opposite ovary. The finding that immunisation against GCIF does not increase
the number of sheep ovulating from both ovaries but does increase the number
of ovulations on the single ovulating ovary indicates that GCIF  is only active in
the ovary in which it is produced and does not affect the opposite ovary. This
failure to affect the opposite ovary in the sheep may indicate that GCIF is
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Table 5.   The frequency distribution of the number of follicles >3mm in
diameter for
Number of follicles class (%)
Immunization  Cycles 0 1 2 3 4 5 6
treatment
HSA 64 17(27) 23(36)  15(23)     9(14) - - -
GCIF-HSA 56 10(18) 15(27) 20(35) 7(12) 2(4) 1(2) 1(2)
The HSA and GCIF-HSA immunisation treatments were not significantly different
(chi-squared test, P>0.05)
restricted to the ovary that produces it but it is more likely that it is due to the
fact that the concentration of GCIF is reduced greatly by dilution in the systemic
blood system. The failure to affect the opposite ovary is an interesting finding; it
would be even more interesting to see if this situation is also the case for mono-
ovulating species such as the cow. These results also indicate clearly that the
immunisation effect on ovulation is not due to some non-specific effect exerted
on the secretion of hypothalamic or pituitary hormones but to a local ovarian
effect. 
This report provides further evidence that a low molecular weight factor in
follicular fluid, GCIF, which inhibits granulosa cell proliferation in vitro also
inhibits large follicle growth and ovulation in vivo and also indicates that it may
be possible to control ovulation rate in cattle by immunisation against this factor.
Immunisation against inhibin  and ovulation rate 
The purpose of this experiment  was to determine whether active immunisation
with a partly purified inhibin preparation derived from cattle follicular fluid would
elicit an immune response to inhibin and affect ovulation rate. Because the
amount of partly purified inhibin available for immunisation studies, prepubertal
lambs were used as a model to determine the effects of immunisation on the
immune response to inhibin and on ovulation rate.
The partly purified inhibin was used directly for immunisation.  Blood samples
were taken  at relevant intervals to measure antibody titres. Following the first
booster injection, vasectomized rams fitted with harnesses and crayons were
used to check for standing estrus in order to establish the time of onset of
puberty and estrous cycle length. Ovulation rate was determined at mid-cycle by
direct laparoscopic observation. 
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The antigen binding capacity of the serum from the immunised lambs was
increased (P<0.002) relative to their pre- immune serum (Fig.5). Radioactive
binding by pre-immune sera was less than 0.5%. The number of ovulations
measured for each of the first three cycles of the season starting approximately
one week after the final boost was 1, 7, and 4 for one of the lambs and 1, 2 and
6 for the other.
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Figure 5   Percentage binding of radioiodinated 68kDa inhibin by serum from ewe
lambs immunized with a partly purified preparation of bovine follicular fluid.
Arrows indicate time of immunization.
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Table 6.  Number of corpora lutea (CL) of control (C) and inhibin
immunized (I) Suffolk x Galway ewe lambs at different ages and mean±
s.e.m. of the within-lamb ovulation rate.
No. of CL at different ages (weeks)      Ovulation
Group N 28 30 31 32 33 38 42 Rate
C 9 3 1 7 1 6 10 2 1.15±0.09
(2) (1) (5) (1) (6) (9) (2)          
I 8 2 5 2 2 4 17 7 1.95±0.28*
(1) (2) (2) (2) (3) (6) (4)          
Values in parentheses are the number of lambs that ovulated.
*Significantly higher than for Group C lambs, P<0.05.
Immunisation increased ovulation rate in the Suffolk cross lambs by 70%
(P<0.05) (Table 6). Ovulation rate in the immunised Finn x Dorset Horn ewe
lambs was 3.38±0.76. This was 47% higher than the ovulation rate of
2.29±0.16 recorded over two cycles for mature ewes (n=12) from the same
flock measured over the same time period (Table 7). There was no effect of
immunisation on the age at puberty or on estrous cycle length in either breed
type (Table 8).
There was no effect of immunisation on the number of Suffolk x Galway lambs
showing estrus or on the number ovulating. However, one inhibin immunised
lamb failed to ovulate despite showing estrous activity on two occasions. A
frequency distribution for ovulation rate is shown in Table 9 for all breeds. 
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Table 7.   Number of corpora lutea (CL) for inhibin immunized Finn x
Dorset Horn ewe lambs at different ages and mean±s.e.m. of the within-
lamb ovulation rate.  
No. of CL at different ages (weeks)      
Group N 32 33 35 36 41 45            
I 4 4 1 4 2 16 17         
(2) (1) (2) (2) (3) (3)            
Values in parentheses are the number of lambs that ovulated.
Ovulation
Rate
3.38±0.76
Table 8.  Effect of immunisation of prepuberal lambs on the onset of
puberty and oestrous cycle length (mean±SEM)
Breed Status N                   Onset of Puberty Cycle       
Type Date* Age(Days) (Days)      
Suffolk x Immunised 8 344±10 224±10 15.3±0.4 (33)
Galway            Control 9 334±07 214±07 15.5±0.3 (44)
Finn x Immunised 4 327±06 235±05 15.8±0.5 (21)
Dorset Horn  Control** 89 321±03 252±03 17.8±0.3 (109) 
* Date is referenced to January 1st = Day 1. ** After Quirke (1978) 
Numbers in parentheses are the number of estrous cycles.
This study shows that active immunisation of prepuberal ewe lambs against a
partly purified preparation of bovine follicular fluid raised antibodies capable of
binding to a homogenous preparation of bovine inhibin. Active immunisation
increased ovulation rate without affecting the onset of puberty or estrous cycle
length. Even though FSH secretion was not measured, these results suggest
that, immunisation against inhibin increases ovulation rate in sheep, possibly by
acting to increase FSH secretion.
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Table 9.    Frequency distribution of ovulation rate for inhibin
immunized (I) and control (C) Suffolk x Galway (SxG) and Finn x Dorset
Horn (FxDH) ewe lambs.
Ovulation Rate Class             
No. of       
Group cycles       1 2 3 4 5 6 9   
I, SxG 20 9 6 4 - - 1 - 
(45) (30) (20) (5)      
C, SxG 26 23 2 1 - - - - 
(88) (8) (4)                           
I, FxDH 13 3 4 2 1 1 - 2 
(23) (31) (15) (8) (8) (15)
C, FxDH 24 3 13 6 2 - - -
(13) (54) (25) (8)
Values in parentheses are percentages.
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5. OVULATION RATE AND FERTILITY IN CATTLE
IMMUNISED AGAINST INHIBIN PEPTIDES
As the amount of inhibin activity that could be purified from bovine follicular fluid
was sufficient only for immunisation of sheep another approach was used for
cattle immunisation.
In this approach the amino acid sequence of the bovine inhibin alpha-subunit was
first analyzed using a computer programme that combined  algorithms for the
prediction of hydrophylicity/hydrophobicity and secondary structure and that
enabled the rapid identification of likely immunological epitopes. From this, three
peptide sequences (Fig. 6) were identified as potential antigenic sites. The natural
sequences were modified during synthesis by the addition of either tyrosyl or
cystenyl residues, linked through a glycine spacer where appropriate, in order to
facilitate iodination and conjugation respectively. The three peptides were
synthesized with a purity of greater than 90%. Each peptide was 
P1:  bI-α-[YG](18-30):[YG]QRPPEEPAAHADC(NH2)
P2:  bI-α-(63-72)[GY]:CGLSPPQDLP[GY](NH2)
P3:  bI-α-[CG](107-122):[CG]HVRTTSDGGYSFKYEM(NH2)
Fig. 6. Sequences of the synthetic peptides derived from the bovine α-inhibin
subunit.
conjugated to human serum albumin (HSA) and conalbumin. Twenty nulliparous
Hereford cross heifers, approximately 18 months of age and 367±7 kg
(mean±sem) in weight were randomly allotted in equal numbers to three
treatment groups and a control group. Three booster injections  were
administered at intervals of 11 weeks. Blood samples were taken  at relevant
intervals to measure anti-peptide antibodies. Five days after each boost, heifers
had their oestrous cycles synchronized.  Ultrasonography was carried out
between Days 6 and 10 on all heifers during each oestrous cycle to determine the
number of ovulations that had occurred. At the first oestrus and the first repeat
oestrus only, following boost 3, heifers were mated. The number of fetuses
present at 45 days after mating was counted by ultrasonography and at
parturition the number of calves born was recorded.
Antibodies were generated to each of the peptides with titres reaching a
maximum between 7 and 21 days following a boost (Fig 7). The highest
individual peptide titres recorded within groups P1, P2 and P3 were 316,000,
284,000 and 59,000 respectively. Peptide titres measured in the HSA immunised
control heifers and in the pre-immune sera were less than 100. 
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Fig. 7. Peptide antibody titres (means±SEM) in serum from heifers immunized
against inhibin peptides (    ) P1, (    )P2, and (    ) P3. Heifers were injected at 
intervals of 11 weeks (arrows). P: primary immunization;B1-B3: consecutive 
booster injections.
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All peptide immunised heifers generated antibodies which bound to inhibin, with
binding reaching a maximum between 7 and 21 days after a boost (Fig 8).  The
highest individual [125I] Mr 32,000 bovine inhibin binding recorded was 35%, 42%
and 13% for P1, P2, and P3 respectively. Inhibin binding in HSA only immunised
heifers and in the pre-immune sera was less than 2%. 
Boost number did not affect (P>0.05) the percentage of radiolabeled inhibin
bound at peak titre. There were significant differences between the peptide
immunised groups in the percentage of radiolabelled inhibin bound at peak titre
(Table 10) with P2 exhibiting the highest binding. Peptide and inhibin titres were
correlated for groups P1 (r=0.46, df=68, P<0.01) and P2 (r=0.74, df=68,
P<0.01) only.
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Fig. 8. Percentage binding (means±SEM) of 125I-labelled 32kDa bovine 
inhibin by  serum from heifers immunized against inhibin peptides (     ) P1, 
(     )P2, and (    ) P3. Heifers were injected at intervals of 11 weeks (arrows).
P: primary immunization;B1-B3: consecutive booster injections.
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The proportion of heifers showing oestrus was not affected (P>0.05) by peptide
immunisation. Oestrous cycle length (least square mean±s.e.m) for groups P1,
P2, P3 and the control group was 19.8 ± 0.5, 20.3 ± 0.5, 19.2 ± 0.5 and 20.6
± 0.5 days, respectively (P>0.05).
The individual animal ovulation response is detailed in Table 12. Peptide
immunisation increased (P<0.05) the ovulation rate overall, however, there was
no difference between peptide groups (P>0.05). In the control group the
ovulation rate was 1.0 at each cycle throughout the immunisation period.
Ovulation rate was increased in 1/5, 5/5 and 4/5 of the heifers and in 6/38 (16%),
13/37 (35%) and 6/33 (18%) of the ovulatory cycles measured following
immunisation against P1, P2 and P3 respectively. Of the 25 multiple ovulatory
cycles recorded, 19 (76%) were twin ovulatory. Boost number did not affect the
ovulation rate (P>0.05), however, there was a significant (P<0.05) effect of
cycle number on ovulation rate and also a significant (P<0.005) treatment by
cycle interaction (Table 12). One heifer (No. 13, P3) became anovulatory for a
period of 60-70 days following boost 2. Ovulation rate in the first oestrous cycle
following a boost and inhibin binding at peak titre were correlated (r=0.56,
df=13, P<0.05) for group P2 only.
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Table 10.  Specific peak inhibin binding (%) following immunization of
heifers with inhibin peptides.
Group                           Inhibin Binding (%)
P1 21.5a 16.5-27.1
(15) 4.6-35.0
P2 27.5b 22.0-33.5
(15) 6.4-42.2
P3 5.5c 2.9 - 8.8
(15) 1.1-13.4
Values are mean followed by 95% confidence limits of the mean of three boosts
with numbers of observations in parentheses and the range.
b>a P<0.05; a,b>c P<0.01.
Data on pregnancy, calving and twin-calving rates are presented in Table 13.
Nine of the 15 peptide immunised heifers and 4 of the 5 control heifers conceived
to first service, as determined by ultrasonography at Day 45.  The remaining 7
heifers conceived to the second service.  The overall conception rate in peptide
immunised heifers for first and second services combined, was 9/11 (82%) and
6/9 (67%) for single and multiple ovulating animals, respectively. Of the 6 heifers
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Table 11. Number of ovulations in successive oestrous cycles following each
of three booster injections for inhibin peptide immunised and control
groups
Booster injection number
1 2 3
Cycle number
Heifer
Group number 1 2 3 4 1 2 3 4 1 2
P1 1 1 1 1 -
$
1 - 1 - 1 -
2 2 1 4 - 1 3 2 - 3 4
3 1 1 1 - 1 1 1 - 1 -
4 1 1 1 1 1 1 1 - 1 -
5 1 1 1 - 1 1 1 1 1 1
P2 6 2 1 1 1 2 1 1 - 3 2
7 1 1 1 1 2 1 1 - 1 -
8 0
§
1 1 - 1 1 2 1 2 -
9 3 1 1 - 2 1 1 - 2 -
10 1 0 1 - 2 2 1 - 2 -
P3 11 2 1 1 - 2 1 1 - 1 1
12 2 - - 1 2 1 1 1 1 -
13 0 1 1 1 0 0 0 - 2 -
14 1 1 1 - 1 1 1 - 2 1
15 1 1 1 - 0 1 1 - 1 -
Control 16 1 1 1 - 1 0 1 - 1 -
17 1 1 1 - 1 1 1 1 1 -
18 1 1 1 1 1 1 1 - 1 1
19 1 1 1 1 1 1 1 - 1 -
20 1 1 1 - 1 1 1 - 1 -
$
No observations were made.  
§
Anovulation
with multiple pregnancies at Day 45, 5 had 2 ovulations and 4 of these produced
twin calves at term. The remaining heifer had 4 ovulations and had 4 foeti at Day
45, all of which were subsequently lost. Two of the 9 peptide-immunised, single-
ovulating heifers, pregnant at Day 45, subsequently lost pregnancies. All 5 single-
ovulating control heifers pregnant at Day 45 subsequently calved.
This study demonstrates that active immunisation of heifers against synthetic
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Table 12. Conception and calving data following breeding after 
booster injection three 
Number of Number of 
Heifer corpora fetuses at Calves
Group number lutea 45 days born
P1 1 1 1 1
2 4(R) 4 0
3 1 1 1
4 1 1 1
5 1(R) 1 1
P2 6 2(R) 2 2
7 1 1 1
8 2 2 2
9 2 2 2
10 2 2 0
P3 11 1(R) 1 0
12 1 1 1
13 2 2 2
14 1(R) 1 0
15 1 1 1
Control   16 1 1 1
17 1 1 1
18 1(R) 1 1
19 1 1 1
20 1 1 1
R: Observation from first repeat oestrus.
peptide sequences of the a-subunit of bovine inhibin can increase ovulation rate
and twin-calving rate. The three inhibin peptides used for immunisation differed
in the ability of the antisera generated to bind to inhibin. Binding was highest for
P2, followed by P1 while binding for P3 was 5-fold lower than P2. The relative
magnitude of the immune response was similar between groups.
Immunisation did not affect either the proportion of heifers showing oestrus or
oestrous cycle length. The highest ovulation rate increase was recorded in group
P2 with all heifers responding with an increased ovulation rate at some time. At
each of the first oestrous cycles following the second and third boosts, 4/5 (80%)
heifers responded with an increased ovulation rate in P2. A total of 11/22 (50%)
ovulatory cycles with multiple ovulations were recorded in group P2 following the
second and third boosts of which 10 (91%) were twin ovulatory. The incidence
of twin ovulations decreased in subsequent cycles even though inhibin binding
was still relatively high, indicating that physiological compensation was occurring
as free antibody titres decreased.
Immunisation against the peptides had no apparent effect on conception or
calving rates. A slightly greater number of the immunised heifers, both single and
multiple ovulating, lost pregnancies after Day 45.  The small numbers of heifers
involved in this study does not allow a firm conclusion to be drawn regarding the
effects of immunisation on pregnancy rate, clearly, however, the production of
4 sets of twin calves from 6 twin ovulatory cycles suggests that peptide
immunisation is a successful approach to the induction of twinning in cattle. This
is the first report of an increase in calving rate following immunisation against
inhibin.
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6. DISCUSSION AND CONCLUSIONS
Ovulation rate is controlled partly by the negative feedback effects of steroids
hormones, at the level of the pituitary to inhibit FSH secretion and partly by locally
produced ovarian factors acting in an autocrine or paracrine manner to affect
follicular growth.  Immunomodulation of the negative feedback effect of steroids
has been successful in increasing ovulation rate in sheep but not in cattle. This
report describes how immunisation against locally produced ovarian factors was
successfully used as an alternative approach to increasing ovulation rate in cattle. 
One of the ovarian factors (GCIF), was isolated in this study and shown to be
present in cattle ovarian follicles. This factor produced by large follicles acts in a
paracrine fashion to inhibit the growth of the smaller or subordinate follicles. Its
effect is local and is limited to the ovary producing it and could thus be considered
as one of the factors involved in the regulation of ovulation rate in cattle.
Immunisation of sheep against GCIF  resulted in a controlled increase in ovulation
rate without  inducing a superovulatory response. Sufficient quantities of GCIF
were not available for cattle immunisation, however, and this will have to await
its chemical characterisation and synthesis. 
Inhibin, also present in small quantities, was isolated from cattle follicular fluid.
Sufficient quantities were recovered to enable immunisation of sheep. In order to
immunise cattle, inhibin peptides derived from the amino acid sequence of bovine
inhibin were synthesized. One of these peptides, which generated the highest
immune response consistently increased the number of twin ovulation in up to 80%
of heifers following a booster immunisation, with a very low incidence of 3
ovulations. Subsequently, following breeding, three heifers from this peptide
immunised group gave birth to twin calves. This is the first time that an increase
in ovulation rate in cattle following immunisation using this approach has resulted
in an increase in the number of calves born. 
Overall, these studies demonstrates that immunomodulation of farm animal
fertility by immunisation against locally produced ovarian factors has potential, not
only to increase ovulation rate but also the number of  calves born.
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